Move to topTop
October 05, 2012

Tokyo -- Terumo Corporation (TSE: 4543 Section 1) today announced that the company determined a site for construction near Ho Chi Minh City, Vietnam for a new factory. The new factory will manufacture the products of blood management business that is one of core corporate strategy.

Factory Overview

Corporate name:

TERUMO BCT VIETNAM CO., LTD.

(To be established in December of FY2012)

Location:

Long Duc Industrial Park, Dong Nai Province, Vietnam

(Suburb of Ho Chi Minh City)

Land area: Approximately 100,000 m2
Investment amount: 98.9 million USD
Projected operation commencement: Summer in 2015 (plan)
Production items: Blood bag, Automated blood collection system disposable kit

In April 2012, Terumo BCT was established through the integration of CaridianBCT and Terumo Transfusion, following Terumo Corporation's acquisition of CaridianBCT in April 2011.

The global demand for blood transfusion will increase due to the growing surgical cases in emerging countries and the increasing platelet transfusion for cancer patients who suffer platelet loss caused by chemotherapy.

To meet these increasing global demands, Terumo BCT will expand the production capacity by the new factory.

About Terumo

Terumo (TSE: 4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for 100 years. Based in Tokyo and operating globally, Terumo employs more than 28,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.

Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts or projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.

 

Information about products (including products currently in development) included in this material is not intended to constitute an advertisement or medical advice.